Prostate Cancer
📧 Sign up to get email alerts when something new happens for Prostate Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2022-10-06Clinical Trial Update: Radiation Therapy With or Without Androgen-Deprivation Therapy in Treating Patients With Prostate Cancer [Phase 3]
This Phase 3 trial compares radiation therapy with versus without androgen-deprivation therapy in men with prostate cancer, with results pos…
-
CLINICAL_TRIALS trial_result · 2022-09-28Clinical Trial Update: Nivolumab and Ipilimumab Treatment in Prostate Cancer With an Immunogenic Signature [Phase 2]
Phase 2 clinical trial update evaluating nivolumab plus ipilimumab in prostate cancer with an immunogenic signature.
-
CLINICAL_TRIALS trial_result · 2022-09-27Clinical Trial Update: Vaccine Therapy in Curative Resected Prostate Cancer Patients [Phase 1, Phase 2]
A phase 1/2 clinical trial update investigating a vaccine therapy in curatively resected prostate cancer patients; current status is unknown…
-
CLINICAL_TRIALS trial_result · 2022-09-27Clinical Trial Update: Genistein Supplementation to Mitigate Cardiometabolic Dysfunction in Patients Undergoing Androgen Deprivation Therapy for Prostate Cancer [Phase 2]
Phase 2 trial evaluating genistein supplementation to mitigate cardiometabolic dysfunction in patients undergoing androgen deprivation thera…
-
CLINICAL_TRIALS trial_result · 2022-09-15Clinical Trial Update: Long-Term TARP Vaccination Using a Multi-Epitope TARP Peptide Autologous Dendritic Cell Vaccination in Previously Vaccinated Men on NCI 09-C-0139 [Phase 2]
Phase 2 trial update on long-term TARP peptide autologous dendritic cell vaccination for prostate cancer; results have been posted.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2022-09-15Clinical Trial Update: Neoadjuvant Androgen Deprivation Therapy Plus Abiraterone With or Without Apalutamide for High-Risk Prostate Cancer [Phase 2]
Phase 2 trial update evaluating neoadjuvant androgen deprivation therapy with abiraterone, with or without apalutamide, for high-risk prosta…
-
CLINICAL_TRIALS trial_result · 2022-09-10Clinical Trial Update: A Phase II Single Arm Pilot Study of the Chk1/2 Inhibitor (LY2606368) in BRCA1/2 Mutation Associated Breast or Ovarian Cancer, Triple Negative Breast Cancer, High Grade Serous Ovarian Cancer, and Metastatic Castrate-Resistant Prostate Cancer [Phase 2]
Phase II single-arm pilot study of the Chk1/2 inhibitor LY2606368 in BRCA1/2 mutation-associated breast or ovarian cancer, triple negative b…
-
CLINICAL_TRIALS trial_result · 2022-09-08Clinical Trial Update: S1216, Phase III ADT+TAK-700 vs. ADT+Bicalutamide for Metastatic Prostate Cancer [Phase 3]
Phase III SWOG trial comparing androgen deprivation therapy plus TAK-700 (Orteronel) versus ADT plus bicalutamide in metastatic prostate can…
-
CLINICAL_TRIALS trial_result · 2022-08-31Clinical Trial Update: LEE011 (Ribociclib) in Combination With Docetaxel Plus Prednisone in mCRPC [Phase 1, Phase 2]
Phase 1/2 trial evaluating LEE011 (ribociclib) in combination with docetaxel and prednisone for metastatic castration-resistant prostate can…
-
CLINICAL_TRIALS trial_result · 2022-08-10Clinical Trial Update: Trial Comparing Radical Radiotherapy to Prostate Only VS Prostate And Pelvic Lymph Nodes in Intermediate And High Risk Prostate Cancer [Phase 2]
A Phase 2 trial comparing radical radiotherapy to prostate-only versus prostate and pelvic lymph nodes in intermediate and high-risk prostat…
-
CLINICAL_TRIALS trial_result · 2022-08-09Clinical Trial Update: Fluciclovine-PET/CT for Bone Metastases From Prostate Adenocarcinoma [NA]
Completed clinical trial evaluating fluciclovine-PET/CT for detecting bone metastases in prostate adenocarcinoma.
-
CLINICAL_TRIALS trial_result · 2022-08-09Clinical Trial Update: 68Ga-P16-093 and 68Ga-PSMA-617 PET/CT Imaging in the Same Group of Prostate Cancer Patients [Phase 2, Phase 3]
Phase 2/3 clinical trial update comparing 68Ga-P16-093 and 68Ga-PSMA-617 PET/CT imaging in the same group of prostate cancer patients.
-
CLINICAL_TRIALS trial_result · 2022-08-08Clinical Trial Update: Docetaxel With or Without Ascorbic Acid in Treating Patients With Metastatic Prostate Cancer [Phase 2]
Phase 2 trial evaluating docetaxel with or without ascorbic acid in metastatic, hormone-resistant prostate cancer has terminated; results po…
-
CLINICAL_TRIALS trial_result · 2022-08-04Clinical Trial Update: A Study of Definitive Therapy to Treat Prostate Cancer [Phase 2]
Phase 2 trial update on definitive therapy for prostate cancer with completed status and posted results.
-
CLINICAL_TRIALS trial_result · 2022-08-03Clinical Trial Update: Biomarker Analysis of Castration-resistant Prostate Cancer Undergoing Bipolar Androgen Therapy [Phase 2]
Phase 2 clinical trial update analyzing biomarkers in prostate cancer patients undergoing bipolar androgen therapy.
-
CLINICAL_TRIALS trial_result · 2022-08-03Clinical Trial Update: Early Salvage Therapy for Patients With Advanced Features for Biochemical Relapse After Radical Prostatectomy for Localized Prostate Carcinoma In Correlation With Supposed Molecular-genetic Parameters of Higher Aggressiveness [Phase 3]
Phase 3 trial evaluating early salvage therapy for biochemical relapse after radical prostatectomy in localized prostate cancer, exploring c…
-
CLINICAL_TRIALS trial_result · 2022-07-13Clinical Trial Update: Enzalutamide and Mifepristone in Treating Patients With Metastatic Hormone Resistant Prostate Cancer [Phase 1, Phase 2]
Phase 1/2 trial evaluating enzalutamide with mifepristone in metastatic hormone-resistant prostate cancer completed with results posted in 2…
-
CLINICAL_TRIALS trial_result · 2022-07-08Clinical Trial Update: An Open-label, Phase II Study of AZD4635 in Patients With Prostate Cancer [Phase 2]
Open-label Phase II trial of AZD4635 in prostate cancer, including metastatic castration-resistant disease; trial completed with results pos…
-
CLINICAL_TRIALS trial_result · 2022-06-29Clinical Trial Update: A Trial Comparing Cardiovascular Safety of Degarelix Versus Leuprolide in Patients With Advanced Prostate Cancer and Cardiovascular Disease [Phase 3]
A Phase 3 trial comparing cardiovascular safety of degarelix versus leuprolide in advanced prostate cancer patients with cardiovascular dise…
-
CLINICAL_TRIALS trial_result · 2022-06-29Clinical Trial Update: Immediate Prostatectomy vs. Cabozantinib Followed by Prostatectomy in Men With High-Risk Prostate Cancer [Phase 2]
Phase 2 trial comparing immediate prostatectomy to cabozantinib followed by prostatectomy in high-risk non-metastatic prostate cancer was te…
-
CLINICAL_TRIALS trial_result · 2022-06-27Clinical Trial Update: RE-sensitizing With Supraphysiologic Testosterone to Overcome REsistance (The RESTORE Study) [Phase 2]
Phase 2 clinical trial assessing supraphysiologic testosterone to resensitize prostate cancer and overcome resistance; study completed with …
-
CLINICAL_TRIALS trial_result · 2022-06-23Clinical Trial Update: Fecal Microbiota Transplant and Pembrolizumab for Men With Metastatic Castration Resistant Prostate Cancer. [Phase 2]
Phase 2 clinical trial exploring fecal microbiota transplant in combination with pembrolizumab for metastatic castration-resistant prostate …
-
CLINICAL_TRIALS trial_result · 2022-06-22Clinical Trial Update: Postoperative Pain, Recovery and Discharge Following Robot-assisted Laparoscopic Prostatectomy [Phase 3]
Phase 3 clinical trial update on postoperative pain, recovery, and discharge after robot-assisted laparoscopic prostatectomy has completed.
-
CLINICAL_TRIALS trial_result · 2022-06-21Clinical Trial Update: Apalutamide and Leuprolide in Intermediate and High-risk Prostate Cancer [Phase 2]
Phase 2 trial evaluating apalutamide with leuprolide in intermediate and high-risk prostate cancer has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2022-06-21Clinical Trial Update: A Phase 2 Trial for Men With Metastatic Prostatic Adenocarcinoma [Phase 2]
Phase 2 trial update for men with metastatic prostatic adenocarcinoma has completed.